Skip to main content

Table 1 Demographic, clinical, and ulcer characteristics after foot surgical procedure

From: Results of a prospective observational study of autologous peripheral blood mononuclear cell therapy for no-option critical limb-threatening ischemia and severe diabetic foot ulcers

 

Study population

N

50

Males, n (%)

31 (62.0)

Age (years), mean ± SD

75.2 ± 10.0

Type 2 diabetes mellitus, n (%)

50 (100.0)

Duration of diabetes (years), mean ± SD

21.0 ± 8.6

Ischemic heart disease, n (%)

29 (58.0)

PB-MNCs treatments, n (%)

 1

12 (24.0)

 2

10 (20.0)

 3

28 (56.0)

Ulcer characteristic

 Right limb, n (%)

23 (46.0)

 Dimension > 5 cm2, n (%)

50 (100.0)

 Infection, n (%)

20 (40.0)

 Gangrene, n (%)

50 (100.0)

 Osteomyelitis, n (%)

30 (60.0)

 Heel location, n (%)

7 (14.0)

Distribution of arterial lesions and vascular findings

 Vessels affected, mean ± SD

3.8 ± 1.8

 Iliac arteries, n (%)

1 (2.0)

 CFA, n (%)

3 (6.0)

 Profunda artery, n (%)

2 (4.0)

 SFA, n (%)

28 (56.0)

 Popliteal artery, n (%)

20 (40.0)

 TPT, n (%)

8 (16.0)

 ATA, n (%)

40 (80.0)

 Peroneal artery, n (%)

22 (44.0)

 PTA, n (%)

40 (80.0)

 Pedidialartery, n (%)

12 (24.0)

 Plantar arteries, n (%)

12 (24.0)

  1. ATA anterior tibial artery, CFA common femoral artery, PB-MNCs peripheral blood mononuclear cells, PTA posterior tibial artery, SD standard deviation, SFA superficial femoral artery, TPT tibiperoneal trunk